# Integer signs development and supply agreements with Respicardia

Integer has entered into a new development agreement and a new supply agreement with Respicardia to be the development partner and majority supplier of the rem edē implantable pulse generator and related products for seven years, with the first 5.5 years as exclusive supplier.

- Type: Contract
- Announced: 2019-01-14
- Where: United States
- Status: announced
- Products: implantable pulse generator, neurostimulation device
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Integer Holdings Corporation](https://endata.com/companies/21565.md)
- [Respicardia](https://endata.com/companies/36689.md) (customer)

## Sources

- [globenewswire.com](https://www.globenewswire.com/news-release/2019/01/14/1691279/26755/en/Integer-Supports-Respicardia-s-Commercialization-in-the-Central-Sleep-Apnea-Market-through-Two-New-Agreements.html), 2019-01-14: "Under the agreements, Integer will be Respicardia’s development partner and majority supplier of the rem edē® implantable pulse generator (IPG) and related products for seven years, the first 5 ½ years as an exclusive supplier."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.